Tag Archives: TEDU

Top 5 High Tech Stocks To Buy Right Now

Nearly everyone has focused on Aurora Cannabis’ (NYSE:ACB) great opportunity in the Canadian recreational marijuana market. The company has gotten off to a pretty good start with that opportunity, capturing a 20% market share in its latest quarter.

But nearly everyone also knows that Aurora’s future rides largely on international medical marijuana markets. The largest of these international opportunities right now is Germany. On Tuesday, Aurora Cannabis announced that it had begun selling cannabis oils to German pharmacies. It’s a milestone that should mean that higher revenue and profit margins are on the way.

Image source: Getty Images.

The leader in Germany

Germany reformed its laws in 2017, allowing easy patient access to medical cannabis and providing full insurance coverage. However, the country didn’t have the infrastructure for domestic cannabis production. That opened the door for Canadian marijuana producers.

Top 5 High Tech Stocks To Buy Right Now: Tarena International, Inc.(TEDU)

Tarena International, Inc., through its subsidiaries, primarily provides information technology (IT) professional education services through part-time and full-time classes in the Peoples Republic of China. It offers education courses in 11 IT subjects, such as Java, .NET, C++, software testing, PHP, embedded, Android, iOS, Big Data, Web front-end development, and Linux and network engineering; and 3 non-IT subjects comprising digital art, online sales and marketing, and accounting through live distance instruction, classroom-based tutoring, and online learning modules. The company also provides two kid education programs, including Tongcheng and Tongmei. Tarena International, Inc. was founded in 2002 and is headquartered in Beijing, the Peoples Republic of China.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Tarena International(NASDAQ:TEDU)Q42018 Earnings Conference CallMarch 11, 2019, 9:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Schroder Investment Management Group trimmed its holdings in Tarena International Inc (NASDAQ:TEDU) by 7.9% in the second quarter, Holdings Channel reports. The fund owned 1,716,054 shares of the business services provider’s stock after selling 146,939 shares during the period. Schroder Investment Management Group’s holdings in Tarena International were worth $12,922,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Shares of Tarena International Inc (NASDAQ:TEDU) have been assigned an average rating of “Hold” from the eight brokerages that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $12.93.

  • [By Max Byerly]

    Tarena International Inc (NASDAQ:TEDU) has received an average rating of “Hold” from the ten analysts that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $16.21.

Top 5 High Tech Stocks To Buy Right Now: Broadcom Corporation(BRCM)

Broadcom Corporation (Broadcom), incorporated in August 16, 1991, provides semiconductor solutions for wired and wireless communications. The Company offers a portfolio of system-on-a-chip solutions (SoCs) that deliver voice, video, data and multimedia connectivity in the home, office and mobile environments. The Company operates in two segments: Broadband and Connectivity, and Infrastructure and Networking. The Companys solutions are used globally by manufacturers and are embedded in an array of communications products.

Broadband and Connectivity

The Companys Broadband and Connectivity segment includes set-top box solutions, broadband modem solutions, connectivity solutions and a range of other technologies. The Companys products include set-top boxes (STBs), central office broadband access equipment, residential gateways, stand-alone broadband access modems and a range of consumer devices, including smartphones and tablets, wearable devices, personal computers (PCs), laptops and access points, among others. Set-top box solutions include transcoding, digital video recording functionality, networking capabilities, and tuners to enable channel change and simultaneous recordings. The Company offers platform solutions for cable, satellite, Internet Protocol and terrestrial STBs. The Company also offers platform solutions for digital subscriber line (DSL), cable and fiber for both central office deployments and consumer premise equipment (CPE).

Broadcoms connectivity solutions include integrated and discrete Wi-Fi, Bluetooth and near field communication (NFC) solutions. The Company offers its wireless connectivity solutions to devices, such as smartphones; tablets; laptops and related peripherals; wireless home routers and gateways; printers; handheld media devices; home gaming systems; smart TVs and connected STBs, as well as a range of wearable and connected devices, including watches and glasses, smoke alarms and thermostats. The Company also offers hi! gh performance, low power Wi-Fi chipsets. The Company supports a range of value added features on top of its Wi-Fi solutions, including WiFi Direct, WiFi Display and Miracast.

The Company offers Bluetooth silicon and software solutions. The Companys other broadband and connectivity technologies include small cell/femtocell solutions, location (GPS) and touch controllers. It offers third generation (3G) or fourth generation (4G) platform solutions for femtocells and small and residential cells. The Company also offers a family of GPS, assisted GPS (A-GPS) and GNSS semiconductor products, software and data services. Its location-based services technology delivers data to its GNSS devices. In addition, the Company offers touch controllers to one customer, which are integrated circuits designed to process signals from touch screens on mobile devices.

Infrastructure and Networking

The Companys Infrastructure and Networking segment includes Ethernet switches and PHYs, which includes switches and fabrics; copper and optical transceivers; backplane and optical front-end physical layer devices; processors, including multicore processors. It offers other Infrastructure and Networking technologies, including knowledge-based processors, voice over Internet protocol (VoIP) solutions, microwave backhaul solutions and radio head digital front ends. The Company also offers a family of Ethernet controllers. The Companys products include service provider metro equipment; edge and core routers, wireless infrastructure and wireless access points; switches and routers; servers and workstations; network interface cards; local area network (LAN) on motherboard applications; optical networks and dense wave division multiplexing applications; security appliances; storage controllers; microwave links for wireless backhaul; cellular remote radio heads; automobile Ethernet networks; point-of-sale equipment, and other embedded system-on-a-chip (SoC) subsystems.

The Compan! y offers ! a set of Ethernet switching products that are optimized for service provider networks, data center implementations, and enterprise and small-and-medium businesses. The Companys service provider switch portfolio enables carrier or service provider networks to support a number of services in the wireless backhaul, access, aggregation and core of their networks. For enterprise applications, the Company offers product families that combine multi-layer switching capabilities and wire-speed Gigabit, 10, 40 and 100 gigabits per second (Gbps) Ethernet switching performance for unified wired and wireless enterprise business networks. Its ethernet copper transceivers are used for high-speed network connections and support energy efficient Ethernet, data encryption and time synchronization at one or 10 Gbps.

Broadcoms BroadR-Reach automotive solutions allow multiple in-vehicle systems, such as infotainment, on-board diagnostics and automated driver assistance to simultaneously access information over unshielded single twisted pair cable. Its automotive Ethernet product portfolio consists of five devices, including three integrated switches with embedded PHYs and two stand-alone PHY solutions. The Company offers a portfolio of 10G and 40G Ethernet transceivers, 100 Gbps gear boxes, forward error correction solutions, and chips for backplanes and optical interconnect to address data traffic both in data centers and service provider networks.

The Company provides multicore processors, integrated processors and networking solutions. The Company offers Ethernet controllers for servers, workstations and desktop and notebook computers, supporting multiple generations of Ethernet technology. It also supplies application-specific integrated circuit (ASIC) controllers through a relationship with QLogic Corporation. Broadcoms knowledge-based processors enable decision-making for packet processing in a variety of devices in the enterprise, metro, access, edge and core networking spaces. The ! Company! s family of microwave and millimeter modems and radio frequency (RF) chip sets allows its customers to build wireless backhaul and LAN extension products for service providers. Its family of VoIP solutions allows its customers to build VoIP-enabled telephony products for the enterprise environment. The Company offers a family of remote radio head digital front-end processors (DFE) products that can be found in wireless infrastructure deployments. In addition, the Company offers customers a range of custom ASIC products.

The Company competes with Intel Corporation, Marvell Technology Group Ltd., Mediatek Inc., Qualcomm Incorporation, STMicroelectronics NV, Cavium, Inc., Freescale Semiconductor,Ltd. and Mellanox.

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Broadcom (NASDAQ:BRCM) have trended somewhat positive this week, according to Accern Sentiment. The research firm scores the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Broadcom earned a news impact score of 0.16 on Accern’s scale. Accern also gave media headlines about the semiconductor manufacturer an impact score of 43.7335359332371 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Paul Ausick]

    Broadcom Inc. (NASDAQ: BRCM) traded down about 1.4% Friday and posted a new 52-week low of $222.00 after closing Thursday at $225.25. The stock’s 52-week high is $285.68. Volume totaled around 3.9 million, just under the daily average of about 4.1 million. The company had no specific news.

Top 5 High Tech Stocks To Buy Right Now: TechTarget, Inc.(TTGT)

TechTarget, Inc. provides specialized online content and marketing services for buyers and sellers of corporate information technology (IT) products and services in the United States and internationally. It offers customized marketing programs, including data analytics-driven intelligence solutions, demand generation, and brand advertising, which enable IT vendors to identify, reach, and influence corporate IT decision makers who are researching specific IT purchases. The companys products include IT deal alert, core online, demand solutions, brand solutions, and custom content creation, which are provided through online, as well as operates face-to-face events. It also operates an integrated content platform that consists of a network of approximately 150 Websites that focus on media groups, such as security, networking, storage, data center and virtualization technologies, chief information officer/IT strategy, business applications and analytics, application architecture and development, channels, and Internet content sites. In addition, the company enables registered members to conduct their pre-purchase research by accessing vendor content across its network of websites. TechTarget, Inc. was founded in 1999 and is headquartered in Newton, Massachusetts.

Advisors’ Opinion:

  • [By Rich Duprey, John Bromels, and Anders Bylund]

    With that kind of mind-set, see why these three Motley Fool contributors believeTechTarget (NASDAQ:TTGT), Royal Dutch Shell (NYSE:RDS-A)(NYSE:RDS-B), and Home Depot (NYSE:HD) are stocks you will want to own for 20 years or more.

  • [By Motley Fool Transcribers]

    TechTarget Inc (NASDAQ:TTGT)Q42018 Earnings Conference CallFeb. 06, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 High Tech Stocks To Buy Right Now: Nucor Corporation(NUE)

Nucor Corporation, together with its subsidiaries, engages in the manufacture and sale of steel and steel products in North America and internationally. It operates through three segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment produces hot and cold-rolled sheet steel; plate steel; structural steel comprising wide-flange beams, beam blanks, and sheet piling; and bar steel, such as blooms, billets, concrete reinforcing bar, merchant bar, and special bar quality products. The Steel Products segment offers steel joists and joist girders, steel deck, fabricated concrete reinforcing steel, cold finished steel, steel fasteners, metal building systems, light gauge steel framing, steel grating and expanded metal, and wire and wire mesh products. The Raw Materials segment produces direct reduced iron (DRI); brokers ferrous and nonferrous metals, pig iron, hot briquetted iron, and DRI; supplies ferro-alloys; and processes ferrous and nonferrous scrap metal products. The company?s operations also include various international trading companies that buy and sell steel and steel products. It sells its hot-rolled steel and cold-rolled steel to steel service centers, fabricators, and manufacturers; steel joists and joist girders, and steel deck to general contractors and fabricators; and cold finished steel and steel fasteners to distributors and manufacturers. The company?s products are used by contractors in constructing highways, bridges, reservoirs, utilities, hospitals, schools, airports, stadiums, and high-rise buildings. Nucor Corporation was founded in 1940 and is based in Charlotte, North Carolina.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Longbow Research lowered shares of Nucor (NYSE:NUE) from a buy rating to a neutral rating in a research note issued to investors on Monday, Marketbeat Ratings reports.

  • [By Logan Wallace]

    Duality Advisers LP bought a new position in Nucor Co. (NYSE:NUE) in the 4th quarter, HoldingsChannel reports. The firm bought 63,770 shares of the basic materials company’s stock, valued at approximately $3,304,000.

  • [By Stephan Byrd]

    Nucor Co. (NYSE:NUE) – Equities researchers at KeyCorp increased their Q1 2019 earnings estimates for shares of Nucor in a report issued on Sunday, March 3rd. KeyCorp analyst P. Gibbs now anticipates that the basic materials company will post earnings of $1.53 per share for the quarter, up from their previous forecast of $1.52. KeyCorp has a “Buy” rating and a $72.00 price objective on the stock. KeyCorp also issued estimates for Nucor’s FY2019 earnings at $5.40 EPS.

Top 5 High Tech Stocks To Buy Right Now: NorthStar Realty Europe Corp.(NRE)

NorthStar Realty Europe Corp., incorporated on June 18, 2015, is a real estate investment trust (REIT). The Company is a European focused commercial real estate company with primary office properties in cities within Germany, the United Kingdom and France. Its objective is to provide its stockholders with stable and recurring cash flow supplemented by capital growth over time. The Company conducts its business through two segments: Real Estate and Corporate. The Real Estate segment includes its European commercial real estate business, which is primarily focused on office properties. The Corporate segment includes corporate level interest expense, management fee, and general and administrative expenses.

The Company’s portfolio consists of approximately 48 properties and a total of approximately 495,588 square meters of rentable space, located in various European markets, including Frankfurt, Hamburg, Berlin, London, Paris, Amsterdam, Milan, Brussels and Madrid. Its portfolio primarily comprises office properties. In addition, the Company owns over two hotels, which are leased to third-party operators. The Company is externally managed and advised by an affiliate of NorthStar Asset Management Group Inc. (NSAM). The Company’s assets, directly or indirectly, are held by, and the Company conducts its operations, directly or indirectly, through its operating partnership, NorthStar Realty Europe Limited Partnership.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Northstar Realty Europe Corp. (NYSE:NRE)Q42018 Earnings Conference CallMarch 13, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Jim Royal]

    Investors in NorthStar Realty Europe (NYSE:NRE) woke up to news Tuesday morning that one of the company’s largest investors is looking to shake things up at the company. SenvestManagement, which owns 9.55% of NorthStar, is pushing the company’s external advisor, Colony Capital (NYSE:CLNY), to realize value at the undervalued European REIT, after years of a stagnating stock price.

  • [By Joseph Griffin]

    Pebblebrook Hotel Trust (NYSE: NRE) and Northstar Realty Europe (NYSE:NRE) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Top 10 Stocks To Buy For 2019

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we’re talking about! Here is some more information if you’re curious.

Welcome to another edition of “3 Things In Biotech,” a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.

Mallinckrodt’s jaundice drug rejected by the FDA

Company: Mallinckrodt (NYSE:MNK)

Therapy: Stannsoporfin

Disease: Severe jaundice

News: MNK announced that a joint advisory committee at the FDA has voted against the risk-benefit profile of its medication stannsoporfin, which was intended to prevent severe hemolysis in newborns who are at risk of severe jaundice. The company guided that it would seek FDA input on what further data might be required in order to get a positive vote in the future.

Looking forward: And so the stannsoporfin story ends…for now! At this time, this looks like a very expensive ($80 million) mistake on the part of MNK, but I think it’s reasonable to expect that it’ll be able to resolve the data issues that sunk this application. But that’s going to take some serious time, and you can probably put this one in the back of your mind for at least another year, I’d wager.

Top 10 Stocks To Buy For 2019: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Coherus Biosciences (NASDAQ: CHRS) and Allena Pharmaceuticals (NASDAQ:ALNA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

  • [By Maxx Chatsko]

    Shares of Coherus BioSciences (NASDAQ:CHRS) gained nearly 49% last month, according to data provided by S&P Global Market Intelligence. The company announced a global settlement with AbbVie that will allow the small-cap biopharma to commercialize a biosimilar to Humira, which was developed as CHS-1420. The pair had previously sparred over patents related to formulating the antibody.

  • [By Maxx Chatsko]

    Shares of Coherus BioSciences (NASDAQ:CHRS) fell over 18% last month, according to data provided by S&P Global Market Intelligence.

    The biopharma stock erupted higher in July after Coherus announced that the Committee for Medicinal Products for Human Use (CHMP) — a European Union regulatory body that makes recommendations to the European Medicines Agency (EMA), which is the equivalent to the U.S. Food and Drug Administration — would reconsider the company’s application for a generic version of Neulasta (pegfilgrastim). That put it on track to getting its first commercial product on the market.

  • [By Stephan Byrd]

    Krystal Biotech (NASDAQ:KRYS) and Coherus Biosciences (NASDAQ:CHRS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Coherus Biosciences (CHRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Buy For 2019: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Daniel Sparks]

    Shares of Chinese internet company Sohu.com (NASDAQ:SOHU) fell as much as 11.8% on Wednesday, following the company’s first-quarter earnings release. The stock is down 8.4% at the time of this writing.

  • [By Rick Munarriz]

    The market isn’t warming up to Sohu.com’s (NASDAQ:SOHU) latest financial report. Its shares are hitting their lowest levels since the summer of 2007 after the Chinese online advertising, search, and gaming specialist posted disappointing first-quarter results on Wednesday morning. 

  • [By Rick Munarriz]

    Lumber Liquidators (NYSE:LL), Camping World Holdings (NYSE:CWH), and Sohu.com (NASDAQ:SOHU) have taken a beating this year. They’re among the biggest losers through the first three quarters of 2018. Let’s go over why I think they have a shot at bouncing back in the next three months.

  • [By Rick Munarriz]

    It’s now been seven months since Sohu.com (NASDAQ:SOHU) completed its objective of spinning off Sogou. Sogou had been the fastest growing component at Sohu for years. It should have taken off after trading on its own merits, but that failed to happen. Though the shares inched slightly higher in their first few days of trading, Sogou has spent most of its time since late November as a broken IPO until it finally cracked the $13 ceiling today in intraday trading.

  • [By Anders Bylund]

    Sogou’s shares are prone to big swings for a couple of simple reasons.

    As a Chinese business, many American investors don’t feel connected to Sogou’s business and might not have access to some important sources of information about this company and its stock. Though Sogou has been around for nearly a decade now, it only entered the public markets in November of 2017. It’s a new ticker, untested on the market, and not always easily understood through year-over-year or longer-term analyses. At the IPO, Chinese internet giants Tencent (NASDAQOTH:TCEHY) and Sohu.com (NASDAQ:SOHU) combined for a total ownership of 82% of Sogu’s business. Those stakes later declined to 71%, but Sohu and Tencent remain Sogou’s largest shareholders, with 96% of the voting power in shareholder elections and votes. Regular investors hold a very small stake in Sogou, which tends to boost the stock’s volatility.

    Moreover, Chinese regulators launched an investigation of Sogou in June, forcing the company to shut down parts of its online advertising operations for 10 days in early July. The company is accused of showing video ads that insulted a national hero. That blackout will reduce Sogou’s third-quarter revenues by a significant but unannounced amount.

  • [By Rick Munarriz]

    Sohu.com (NASDAQ:SOHU) is still struggling to fire on all cylinders, but investors nonetheless bid shares of the dot-com pioneer higher on Friday after it posted mixed fourth-quarter results. Revenue clocked in at $482.2 million for the final three months of 2018, a 5% decline from a year earlier, but a 5% sequential improvement. 

Top 10 Stocks To Buy For 2019: LGI Homes, Inc.(LGIH)

Advisors’ Opinion:

  • [By Tyler Crowe]

    This isn’t to say that investing in homebuilding is an awful idea — the trends mentioned above are incredibly strong indicators that investing in housing can pay off. What matters is you have to be incredibly discerning when selecting the business in which you want to invest. To me, there are only two stocks that are really worth exploring as potential investments: LGI Homes (NASDAQ:LGIH) and NVR Inc. (NYSE:NVR). Here’s why these two homebuilders stand out among the crowd.

  • [By ]

    LG Homes (LGIH) : “I like Lennar (LEN) and I also like Toll Brothers (TOL) .”

    GrubHub (GRUB) : “I’ve been riding this one for a long time. It might be time to take some profits. “

  • [By Neha Chamaria, Jason Hall, and Dan Caplinger]

    So, when we asked three of our Motley Fool contributors to each name a stock that has doubled and still has room to grow, they picked lululemon athletica (NASDAQ:LULU), LGI Homes Inc (NASDAQ:LGIH), and XPO Logistics (NYSE:XPO). Here’s why.

  • [By Shane Hupp]

    LGI Homes Inc (NASDAQ:LGIH) – Wedbush decreased their Q2 2019 earnings per share (EPS) estimates for shares of LGI Homes in a report released on Friday, July 6th. Wedbush analyst J. Mccanless now anticipates that the financial services provider will post earnings per share of $1.58 for the quarter, down from their previous forecast of $1.61. Wedbush has a “Neutral” rating and a $65.00 price objective on the stock. Wedbush also issued estimates for LGI Homes’ Q3 2019 earnings at $2.13 EPS and Q4 2019 earnings at $2.79 EPS.

Top 10 Stocks To Buy For 2019: T. Rowe Price Group, Inc.(TROW)

Advisors’ Opinion:

  • [By ]

    T Rowe Price (Nasdaq: TROW) — It has been a tough stretch for many money managers, as investors siphon assets away from traditional mutual funds and deposit them in passive exchange-traded funds (ETFs). But T. Rowe Price bucked the trend and attracted $2.7 billion in net inflows last quarter, raising its assets under management (AUM) to $1.08 trillion.

  • [By Chris Lange]

    The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was T. Rowe Price Group, Inc. (NASDAQ: TROW) which fell about 5% to $107.70. The stock’s 52-week range is $81.77 to $127.43. Volume was about 2.5 million compared to the daily average volume of 1.1 million.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on T. Rowe Price Group (TROW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Press coverage about T. Rowe Price (NASDAQ:TROW) has trended somewhat positive on Wednesday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. T. Rowe Price earned a news impact score of 0.20 on Accern’s scale. Accern also assigned media stories about the asset manager an impact score of 47.382716620203 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By ]

    T Rowe Price (Nasdaq: TROW) — It has been a tough stretch for many money managers, as investors siphon assets away from traditional mutual funds and deposit them in passive exchange-traded funds (ETFs). But T. Rowe Price bucked the trend and attracted $2.7 billion in net inflows last quarter, raising its assets under management (AUM) to $1.08 trillion.

  • [By Max Byerly]

    T. Rowe Price Group Inc (NASDAQ:TROW) Director Robert F. Maclellan sold 5,000 shares of T. Rowe Price Group stock in a transaction on Wednesday, May 30th. The shares were sold at an average price of $122.58, for a total value of $612,900.00. Following the completion of the transaction, the director now owns 13,769 shares in the company, valued at $1,687,804.02. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Top 10 Stocks To Buy For 2019: JA Solar Holdings, Co., Ltd.(JASO)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Bank of America Corp. (NYSE: BAC) leads a strong day of earnings reports on Wall Street. The commercial banking giant was expected to report earnings per share (EPS) of $0.57 on top of $22.4 billion in revenue. The company topped both numbers, including EPS of $0.63. The company said its performance was bolstered by stronger profit margins, the 2017 GOP tax plan, and higher revenue from banking fees. President Donald Trump will meet with Russian President Vladimir Putin in Helsinki, Finland. Trump could request that Russia assist with the denuclearization of North Korea during their summit. Trump has said that he expects that he and Putin will have an “extraordinary friendship” at the conclusion of the event. The meeting comes just days after the U.S. government announced 12 indictments against Russian officials on charges of conspiracy to interfere with the 2016 presidential election. Global growth is back in focus after China announced second-quarter GDP expectations. The government announced that Q2 GDP came in at 6.7% as the country has been cracking down on risky credit offerings. Markets are continually worried about China’s Shanghai Composite – which recently entered bear territory. The third quarter will be interesting for markets as trade tensions accelerate between the United States and China.
    Four Stocks to Watch Today: NFLX, AMZN, TWTR, CAT
    Shares of Netflix Inc. (Nasdaq: NFLX) are in focus as the company prepares to report earnings after the bell. Wall Street analysts project that the company will report EPS of $0.80 on top of $3.93 billion in revenue. Analysts will be paying close attention to whether the online-streaming giant has been able to continue to aggressively increase its international user base. Amazon.com Inc. (Nasdaq: AMZN) is generating buzz as the company prepares to kick-start its annual Prime Day. The annual shopping event will take place starting this evening and stretch through Tuesday. According to the website Reta

  • [By Travis Hoium]

    The impact will have ripple effects across the industry. Major manufacturers like Canadian Solar (NASDAQ:CSIQ), JinkoSolar (NYSE:JKS), Hanwha Q Cells (NASDAQ:HQCL), and JA Solar (NASDAQ:JASO) will see margins squeezed as volume and sales prices fall. They were all enjoying higher margins and strong demand in early 2018, so the could reverse to net losses later this year. 

  • [By Rich Smith]

    Fearing that prospects for the solar industry are dimming, yesterday analysts at Roth Capital bailed on the solar industry wholesale, downgrading shares of Hanwha Q Cells, JA Solar Holdings (NASDAQ:JASO), and ReneSola to sell. This morning, Merrill Lynch showed signs it’s planning to join the rush to the exits as well, downgrading American solar manufacturer First Solar (NASDAQ:FSLR) to neutral.

  • [By Garrett Baldwin]

    We’re about to reveal a little wealth secret that could unlock the trade of a lifetime. Money Morning Special Situation Strategist Tim Melvin takes you inside what could easily be a 10-bagger for investors in the weeks ahead. Read more right here.

    The Top Stock Market Stories for Tuesday
    The Euro has plunged to its lowest point against the U.S. dollar in 2018 thanks to political problems in Europe. The breakdown of power in Italy has raised new concerns about the nation’s ability to repay its debts, as the spread between German and Italian bonds has widened. Market instability has also spread to Spain where the nation’s parliament is preparing to vote on whether to oust Prime Minister Mariano Rajoy and his party. Oil prices slid one news that OPEC and Russia will consider hikes in production during a meeting in Vienna, Austria on June 22nd. The news accompanied reports that U.S. production is expected to rise throughout the summer. The price of WTI oil sat at $67.20 per barrel. The Brent crude oil price recovered this morning, adding 1% to hit $76.12. Canadian banks are under pressure this morning over a major breach by cyber criminals. The Bank of Montreal (NYSE: BMO) and the Canadian Imperial Bank of Commerce (NYSE: CM) – the two largest banking institutions in the country – announced that roughly 90,000 customers’ data may have been stolen. This would be the first major cybersecurity event to happen in Canada involving financial firms.
    Three Stocks to Watch Today: CRM, SBUX, MOMO
    com (NYSE: CRM) will lead a busy day of earnings reports on Wall Street. The cloud computing giant is set to report fiscal first quarter 2019 numbers after the bell on Tuesday. The average analyst projection calls for a 46% jump in EPS of $0.46 on top of a 23% gain in revenue to $2.94 billion. Starbucks’ Corporation (Nasdaq: SBUX) will temporarily close about 8,000 locations on Tuesday to train roughly 175,000 employees on racial bias. The training sessions were

  • [By Ethan Ryder]

    JA Solar (NASDAQ:JASO) is scheduled to be posting its quarterly earnings results before the market opens on Monday, July 2nd. Analysts expect JA Solar to post earnings of $0.20 per share for the quarter.

Top 10 Stocks To Buy For 2019: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Tarena International Inc. (ADR) (NASDAQ:TEDU) plummeted 22.1% on Tuesday after the China-based professional education services provider announced disappointing first-quarter 2018 results. 

  • [By Joseph Griffin]

    Schroder Investment Management Group trimmed its holdings in Tarena International Inc (NASDAQ:TEDU) by 7.9% in the second quarter, Holdings Channel reports. The fund owned 1,716,054 shares of the business services provider’s stock after selling 146,939 shares during the period. Schroder Investment Management Group’s holdings in Tarena International were worth $12,922,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Credit Suisse Group cut shares of Tarena International (NASDAQ:TEDU) from an outperform rating to a neutral rating in a report published on Thursday morning, Marketbeat reports.

Top 10 Stocks To Buy For 2019: Peapack-Gladstone Financial Corporation(PGC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Thrivent Financial for Lutherans lifted its position in shares of Peapack-Gladstone Financial Co. Common Stock (NASDAQ:PGC) by 16.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 48,531 shares of the financial services provider’s stock after purchasing an additional 6,789 shares during the quarter. Thrivent Financial for Lutherans owned about 0.26% of Peapack-Gladstone Financial Co. Common Stock worth $1,621,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Peapack-Gladstone Financial Co. Common Stock (PGC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Bank of N.T. Butterfield & Son (NYSE: NTB) and Peapack-Gladstone Financial Co. Common Stock (NASDAQ:PGC) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends.

Top 10 Stocks To Buy For 2019: Evoke Pharma, Inc.(EVOK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Evoke Pharma (EVOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Here are some of the news stories that may have impacted Accern’s rankings:

    Get Evoke Pharma alerts:

    Evoke Pharma (EVOK) Given a $9.00 Price Target by HC Wainwright Analysts (americanbankingnews.com) Evoke Pharma (EVOK) Announces FDA Acceptance of Gimoti NDA (zacks.com) FDA to Review Gimoti for Diabetic Gastroparesis in Adult Women (empr.com) Evoke Pharma’s Gimoti™ NDA Accepted for FDA Review (finance.yahoo.com)

    Shares of NASDAQ EVOK traded up $0.08 during mid-day trading on Friday, reaching $2.44. 56,399 shares of the company’s stock were exchanged, compared to its average volume of 83,661. The stock has a market cap of $42.58 million, a PE ratio of -2.94 and a beta of 1.46. Evoke Pharma has a 52-week low of $1.85 and a 52-week high of $4.09.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Evoke Pharma (EVOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Buy For 2019: CommVault Systems, Inc.(CVLT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CommVault Systems (CVLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CommVault Systems (CVLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    CommVault Systems, Inc. (NASDAQ:CVLT) has been assigned an average rating of “Buy” from the eleven analysts that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $76.57.

Top 10 Stocks To Buy For 2019: BlackRock Multi-Sector Income Trust(BIT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Northwestern Mutual Wealth Management Co. increased its stake in Blackrock Multi-Sector Income Trust (NYSE:BIT) by 23.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,769 shares of the investment management company’s stock after purchasing an additional 15,675 shares during the quarter. Northwestern Mutual Wealth Management Co. owned 0.22% of Blackrock Multi-Sector Income Trust worth $1,415,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    First Bitcoin (CURRENCY:BIT) traded up 12.4% against the US dollar during the one day period ending at 7:00 AM E.T. on July 1st. One First Bitcoin coin can now be bought for approximately $0.0113 or 0.00000177 BTC on major exchanges. Over the last week, First Bitcoin has traded 4% lower against the US dollar. First Bitcoin has a market capitalization of $0.00 and approximately $13.00 worth of First Bitcoin was traded on exchanges in the last day.

  • [By Max Byerly]

    BitRewards (CURRENCY:BIT) traded 7.8% lower against the US dollar during the 24-hour period ending at 19:00 PM E.T. on August 13th. One BitRewards token can now be purchased for approximately $0.0017 or 0.00000027 BTC on exchanges including IDEX and HitBTC. BitRewards has a total market capitalization of $414,691.00 and $106,200.00 worth of BitRewards was traded on exchanges in the last 24 hours. Over the last week, BitRewards has traded down 31.6% against the US dollar.

Best Penny Stocks To Watch For 2019

After markets closed on Monday, rental car company Hertz Global Holdings Inc. (NYSE: HTZ) and real-estate firm Zillow Group Inc. (NASDAQ: Z) reported quarterly results. Before markets opened Tuesday morning Discovery Inc. (NASDAQ: DISCA) and Dish Network Corp. (NASDAQ: DISH) also released earnings reports. Here’s a quick look at the reports and the reactions to them.

Hertz revenue was up 5% year over year to $1.43 billion in the first quarter, and the adjusted net loss totaled $1.58 per share, down slightly from a loss of $1.61 in the same quarter last year. Analysts had forecast an adjusted net loss of $1.26 per share and revenues of $1.97.

The big miss on both revenues and earnings hit the stock hard. Shares traded down almost 8% in Tuesday’s premarket session to $20.40, after closing at $22.16 Monday. The 52-week trading range is $8.52 to $27.27 and the 12-month price target on the stock is $21.29.

Zillow reported revenues of $299.88 million for the first quarter and adjusted diluted earnings per share of $0.07. The totals beat earnings per share estimates by a penny and revenues by nearly $2 million. The company’s second-quarter revenue guidance of $322 million to $327 million fell way short of the consensus estimate of $343 million.

Best Penny Stocks To Watch For 2019: UFP Technologies Inc.(UFPT)

Advisors’ Opinion:

  • [By Logan Wallace]

    China XD Plastics (NASDAQ: CXDC) and UFP Technologies (NASDAQ:UFPT) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

  • [By Ethan Ryder]

    Media coverage about UFP Technologies (NASDAQ:UFPT) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. UFP Technologies earned a daily sentiment score of 0.03 on Accern’s scale. Accern also assigned headlines about the industrial products company an impact score of 47.0533500754779 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Joseph Griffin]

    UFP Technologies (NASDAQ: UFPT) and China XD Plastics (NASDAQ:CXDC) are both small-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.

Best Penny Stocks To Watch For 2019: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Max Byerly]

    Tarena International Inc (NASDAQ:TEDU) has received an average rating of “Hold” from the ten analysts that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $16.21.

  • [By Logan Wallace]

    Tarena International (NASDAQ: TEDU) and Aspen Group (NASDAQ:ASPU) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

  • [By Dan Caplinger]

    Tuesday was a calm day on Wall Street, with several major benchmarks posting modest gains while others stayed closer to the unchanged mark. Market participants generally seemed ready to take a pause in trends over the past several days, as crude oil prices bounced back from their recent drop to climb above $65 per barrel while interest rates eased slightly lower. Yet despite a resilient market that largely avoided most downward pressure, some individual stocks weren’t as lucky. Carnival (NYSE:CCL) (NYSE:CUK), Tarena International (NASDAQ:TEDU), and Genesco (NYSE:GCO) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Max Byerly]

    K12 (NYSE: LRN) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

  • [By Stephan Byrd]

    RYB Education (NYSE: RYB) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.

  • [By Steve Symington]

    Shares of Tarena International Inc. (ADR) (NASDAQ:TEDU) plummeted 22.1% on Tuesday after the China-based professional education services provider announced disappointing first-quarter 2018 results. 

Best Penny Stocks To Watch For 2019: Corcept Therapeutics Incorporated(CORT)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Corcept Therapeutics Inc. (NASDAQ:CORT) fell over 17% on Friday after the company announced second-quarter and first-half 2018 earnings results. The business reported significant growth in both revenue and net income thanks to strong market traction for its drug Korlym. Despite the growth, management decided to walk back its original full-year 2018 revenue guidance to a new range of $250 million to $270 million, down from the previous range of $275 million to $300 million. 

  • [By Maxx Chatsko]

    Shares of Corcept Therapeutics (NASDAQ:CORT) gained over 11% last month, according to data provided by S&P Global Market Intelligence. The double-digit rise might seem impressive, but it comes on the heels of a report by the Southern Investigative Reporting Foundation (SIRF) that painted the company and its main profit generator, Korlym, a drug approved to treat Cushing’s syndrome, in a negative light. That caused the stock to plunge in late January. As a result, shares have posted a year-to-date loss of 6% through the first week of March.

  • [By Jamie Dlugosch]

    For 2019, analysts expect Corcept Therapeutics Inc. (NASDAQ: CORT) to grow profits by 66%.

    Trading for 20 times earnings, Corcept is quite the bargain relative to expected growth.

  • [By Ethan Ryder]

    ValuEngine lowered shares of Corcept Therapeutics (NASDAQ:CORT) from a buy rating to a hold rating in a research note issued to investors on Friday.

  • [By Ethan Ryder]

    BidaskClub upgraded shares of Corcept Therapeutics (NASDAQ:CORT) from a sell rating to a hold rating in a research report report published on Monday morning.

  • [By Brian Feroldi, Anders Bylund, and Maxx Chatsko]

    So which growth stocks are worthy of an investment today? We asked three Motley Fool contributors to weigh in and they called out Corcept Therapeutics (NASDAQ:CORT), Tucows (NASDAQ:TCX), and New Relic (NYSE:NEWR). 

Top 5 Blue Chip Stocks To Buy For 2019

Chicago Equity Partners LLC decreased its position in Cummins (NYSE:CMI) by 9.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 35,290 shares of the company’s stock after selling 3,515 shares during the period. Chicago Equity Partners LLC’s holdings in Cummins were worth $5,720,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Advisor Partners LLC boosted its holdings in shares of Cummins by 8.1% in the fourth quarter. Advisor Partners LLC now owns 3,596 shares of the company’s stock valued at $680,000 after purchasing an additional 269 shares during the period. Parallel Advisors LLC boosted its holdings in shares of Cummins by 6.4% in the fourth quarter. Parallel Advisors LLC now owns 5,004 shares of the company’s stock valued at $884,000 after purchasing an additional 303 shares during the period. Baird Financial Group Inc. boosted its holdings in shares of Cummins by 1.1% in the fourth quarter. Baird Financial Group Inc. now owns 28,069 shares of the company’s stock valued at $4,958,000 after purchasing an additional 310 shares during the period. Jacobs & Co. CA boosted its holdings in shares of Cummins by 1.3% in the fourth quarter. Jacobs & Co. CA now owns 25,673 shares of the company’s stock valued at $4,483,000 after purchasing an additional 330 shares during the period. Finally, Blue Chip Partners Inc. boosted its holdings in shares of Cummins by 9.2% in the fourth quarter. Blue Chip Partners Inc. now owns 4,179 shares of the company’s stock valued at $738,000 after purchasing an additional 353 shares during the period. Hedge funds and other institutional investors own 83.40% of the company’s stock.

Top 5 Blue Chip Stocks To Buy For 2019: Edwards Lifesciences Corporation(EW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Aperio Group LLC raised its holdings in shares of Edwards Lifesciences (NYSE:EW) by 15.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 96,340 shares of the medical research company’s stock after acquiring an additional 13,223 shares during the quarter. Aperio Group LLC’s holdings in Edwards Lifesciences were worth $13,441,000 as of its most recent filing with the SEC.

  • [By Motley Fool Transcribers]

    Edwards Lifesciences Corp  (NYSE:EW)Q4 2018 Earnings Conference CallJan. 31, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By ]

    In the Lightning Round, Cramer was bullish on Align Technology (ALGN) , Regions Financial (RF) , Edwards Lifesciences (EW) , Qualys (QLYS) and HEICO (HEI) .

Top 5 Blue Chip Stocks To Buy For 2019: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Max Byerly]

    K12 (NYSE: LRN) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

  • [By Steve Symington]

    Shares of Tarena International Inc. (ADR) (NASDAQ:TEDU) plummeted 22.1% on Tuesday after the China-based professional education services provider announced disappointing first-quarter 2018 results. 

  • [By Joseph Griffin]

    Credit Suisse Group cut shares of Tarena International (NASDAQ:TEDU) from an outperform rating to a neutral rating in a report published on Thursday morning, Marketbeat reports.

  • [By Stephan Byrd]

    RYB Education (NYSE: RYB) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.

  • [By Ethan Ryder]

    Shares of Tarena International Inc (NASDAQ:TEDU) have been assigned an average rating of “Hold” from the eight brokerages that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $12.93.

Top 5 Blue Chip Stocks To Buy For 2019: Salesforce.com Inc(CRM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    salesforce.com, inc. (NYSE:CRM) CFO Mark J. Hawkins sold 8,221 shares of salesforce.com stock in a transaction dated Wednesday, September 26th. The shares were sold at an average price of $158.68, for a total value of $1,304,508.28. Following the completion of the sale, the chief financial officer now directly owns 28,277 shares in the company, valued at approximately $4,486,994.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Nicholas Rossolillo]

    The expansion of enterprise software provider Salesforce (NYSE:CRM) has been relentless, and that has put the company at odds with Microsoft (NASDAQ:MSFT) many times. Since Microsoft CEO Satya Nadella took over a few years ago, the relationship between the two competitors has warmed compared with the cold war they used to wage. Salesforce and Microsoft customers can even integrate the two software platforms, a capability that is advertised on both companies’ websites.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on salesforce.com (CRM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Blue Chip Stocks To Buy For 2019: Chimerix, Inc.(CMRX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Chimerix (CMRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Chimerix Inc (NASDAQ:CMRX) Director Ernest Mario sold 45,000 shares of the firm’s stock in a transaction dated Friday, May 18th. The shares were sold at an average price of $4.80, for a total value of $216,000.00. Following the transaction, the director now owns 12,905 shares of the company’s stock, valued at $61,944. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Top 5 Blue Chip Stocks To Buy For 2019: PACCAR Inc.(PCAR)

Advisors’ Opinion:

  • [By Shane Hupp]

    BidaskClub downgraded shares of PACCAR (NASDAQ:PCAR) from a sell rating to a strong sell rating in a research report released on Saturday morning.

    Several other analysts also recently weighed in on the company. JPMorgan Chase & Co. lowered their price objective on PACCAR from $74.00 to $72.00 and set a hold rating for the company in a research report on Tuesday, April 10th. Deutsche Bank downgraded PACCAR from a hold rating to a sell rating and set a $77.00 price objective for the company. in a research report on Monday, March 19th. Zacks Investment Research downgraded PACCAR from a buy rating to a hold rating in a research report on Tuesday, April 3rd. ValuEngine upgraded PACCAR from a hold rating to a buy rating in a research report on Tuesday, April 3rd. Finally, Robert W. Baird reiterated a hold rating and issued a $80.00 price objective on shares of PACCAR in a research report on Tuesday, April 17th. Five investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and five have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus price target of $73.30.

  • [By Neha Chamaria]

    However, recalls aren’t anything new in the transportation industry. Cummins’ largest customer PACCAR (NASDAQ:PCAR), for instance, is recalling more than 3,000 Peterbilt and Kenworth trucks to fix a brakes defect, after another 2,000 or so trucks earlier this year for a transmissions-display issue.

  • [By Ethan Ryder]

    KBC Group NV increased its position in shares of Paccar (NASDAQ:PCAR) by 9.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 92,983 shares of the company’s stock after purchasing an additional 7,832 shares during the quarter. KBC Group NV’s holdings in Paccar were worth $6,153,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Hudson Capital Management LLC grew its position in shares of PACCAR Inc (NASDAQ:PCAR) by 8.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,965 shares of the company’s stock after buying an additional 1,798 shares during the quarter. Hudson Capital Management LLC’s holdings in PACCAR were worth $1,423,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Joseph Griffin]

    Northwestern Mutual Investment Management Company LLC lowered its position in Paccar (NASDAQ:PCAR) by 19.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 64,069 shares of the company’s stock after selling 15,351 shares during the quarter. Northwestern Mutual Investment Management Company LLC’s holdings in Paccar were worth $4,239,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Heal Care Stocks To Invest In Right Now

Celgene Corp. (NASDAQ:CELG) investors would probably like a few do-overs given the company’s stumbles over the past year. First, it suffered a key clinical-trial failure that forced it to ratchet back its long-term sales outlook. Then, the FDA sent it an embarrassing Refusal to File letter for its most-anticipated drug, ozanimod.

The setbacks have increased the pressure on the company to deliver a win, and fortunately, that win came in the form of positive pivotal-stage trial results for luspatercept, a drug that Celgene has licensed from Acceleron Pharma (NASDAQ:XLRN). On Thursday, the companies announced that luspatercept’s late-stage study in myelodysplastic syndromes (MDS) panned out, clearing the way for filings for approval next year. How big is this win for Celgene?

What’s going on

Luspatercept addresses chronic anemia in MDS by promoting the production of healthy red blood cells and regulating TGF-beta proteins involved in the late stages of creating red blood cells.

Top 10 Heal Care Stocks To Invest In Right Now: Computer Programs and Systems Inc.(CPSI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Millrace Asset Group Inc. acquired a new position in shares of Computer Programs & Systems, Inc. (NASDAQ:CPSI) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 45,000 shares of the company’s stock, valued at approximately $1,314,000. Millrace Asset Group Inc. owned about 0.32% of Computer Programs & Systems at the end of the most recent quarter.

  • [By Max Byerly]

    Computer Programs & Systems, Inc. (NASDAQ:CPSI) has received an average rating of “Hold” from the nine brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, one has given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $30.80.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Computer Programs & Systems (CPSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Computer Programs & Systems (NASDAQ: CPSI) and Perion Network Ltd Common Stock (NASDAQ:PERI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Top 10 Heal Care Stocks To Invest In Right Now: RPX Corporation(RPXC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Research Frontiers (NASDAQ: REFR) and RPX (NASDAQ:RPXC) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.

  • [By Logan Wallace]

    Thompson Siegel & Walmsley LLC lifted its position in RPX Co. (NASDAQ:RPXC) by 32.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 787,377 shares of the business services provider’s stock after purchasing an additional 192,430 shares during the period. Thompson Siegel & Walmsley LLC owned about 1.58% of RPX worth $8,417,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    RPX (NASDAQ:RPXC) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Wednesday.

  • [By Dan Caplinger]

    Patent litigation abuse is a major problem in the tech industry, and policymakers have looked for ways to fight it. RPX (NASDAQ:RPXC) came up with a unique approach to patent protection involving purchases of various intellectual property to deter would-be plaintiffs from challenging ownership. Yet the market for those services hasn’t grown the way some had anticipated, and even after diversifying into legal discovery services, RPX saw little choice but to start pursuing strategic alternatives to come up with a future direction for its business.

Top 10 Heal Care Stocks To Invest In Right Now: Hertz Global Holdings Inc(HTZ)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the news stories that may have effected Accern’s rankings:

    Get Hertz Global alerts:

    Trending Most Active Stock: Hertz Global Holdings, Inc. (HTZ) (nasdaqplace.com) Why is the 200 Simple Moving Average (SMA) so common for traders and analysts? Novavax, Inc. (NASDAQ:NVAX … (thestreetpoint.com) Hertz Global Holdings, Inc. (HTZ): That’s where you can keep the ball in your court (fintelegraph.com) Is Hertz Global Holdings Inc (NYSE:HTZ) A Financially Sound Company? (finance.yahoo.com) Hertz Global Hol Rises 1.95% on Heavy Volume: Watch For Potential Pullback (mysmartrend.com)

    A number of brokerages have commented on HTZ. ValuEngine upgraded shares of Hertz Global from a “hold” rating to a “buy” rating in a report on Thursday, June 7th. Zacks Investment Research downgraded shares of Hertz Global from a “hold” rating to a “sell” rating in a report on Tuesday, May 15th. Four equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $15.71.

  • [By Demitrios Kalogeropoulos]

    Hertz Global Holdings(NYSE:HTZ) shed 31% last month compared to a 2% increase in the S&P 500, according to data provided by S&P Global Market Intelligence.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

  • [By Dan Caplinger]

    Wall Street had another good session on Tuesday, with favorable earnings reports from some of the nation’s most successful technology companies helping to lift major benchmarks by 1% or more. Investors haven’t forgotten about some of the potential pitfalls that could derail the recovery, including both geopolitical and macroeconomic concerns. Yet traders seem to want to see the market test its all-time highs before deciding whether the correction could turn into a full-fledged bear market reversal. Some individual stocks, however, missed out on the good times. GoPro (NASDAQ:GPRO), Apellis Pharmaceuticals (NASDAQ:APLS), and Hertz Global Holdings (NYSE:HTZ) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern’s rankings:

    Get Hertz Global alerts:

    Hertz Global Holdings, Inc (HTZ) CFO Thomas C. Kennedy Buys 15,000 Shares (americanbankingnews.com) Northcoast Research Weighs in on Hertz Global Holdings, Inc’s Q2 2018 Earnings (HTZ) (americanbankingnews.com) Hertz Global Target of Unusually High Options Trading (HTZ) (americanbankingnews.com) Edited Transcript of HTZ earnings conference call or presentation 8-May-18 12:00pm GMT (finance.yahoo.com) Hertz Sweeps 2018 FlyerTalk Awards (finance.yahoo.com)

    Several equities research analysts have issued reports on HTZ shares. Zacks Investment Research upgraded Hertz Global from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. Macquarie upgraded Hertz Global from a “neutral” rating to an “outperform” rating in a research report on Thursday, January 18th. Goldman Sachs dropped their target price on Hertz Global from $15.00 to $13.00 and set a “sell” rating on the stock in a research report on Thursday, February 15th. Finally, ValuEngine downgraded Hertz Global from a “hold” rating to a “sell” rating in a research report on Thursday, February 15th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $15.71.

Top 10 Heal Care Stocks To Invest In Right Now: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After disclosing that the Food and Drug Administration is asking for more information before signing off on a phase 1 study of its “Sleeping Beauty” CAR-T for leukemia and lymphoma, shares in Ziopharm Oncology (NASDAQ:ZIOP) were tumbling 17.7% at 3 p.m. EDT today.

  • [By George Budwell]

    Shares of the clinical-stage biotech Ziopharm Oncology (NASDAQ:ZIOP) rose by a healthy 16% last month,according toS&P Global Market Intelligence. What sparked this sizable rally?

  • [By Keith Speights]

    If you like putting money into the beaten-down stocks of clinical-stage biotechs, Ziopharm Oncology (NASDAQ:ZIOP) and Celldex Therapeutics (NASDAQ:CLDX) might warrant a look. Ziopharm’s share price has dropped more than 25% so far in 2018, while Celldex stock has plunged more than 80%.

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Top 10 Heal Care Stocks To Invest In Right Now: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Tuesday was a calm day on Wall Street, with several major benchmarks posting modest gains while others stayed closer to the unchanged mark. Market participants generally seemed ready to take a pause in trends over the past several days, as crude oil prices bounced back from their recent drop to climb above $65 per barrel while interest rates eased slightly lower. Yet despite a resilient market that largely avoided most downward pressure, some individual stocks weren’t as lucky. Carnival (NYSE:CCL) (NYSE:CUK), Tarena International (NASDAQ:TEDU), and Genesco (NYSE:GCO) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Steve Symington]

    Shares of Tarena International Inc. (ADR) (NASDAQ:TEDU) plummeted 22.1% on Tuesday after the China-based professional education services provider announced disappointing first-quarter 2018 results.

  • [By Max Byerly]

    K12 (NYSE: LRN) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

  • [By Logan Wallace]

    Tarena International (NASDAQ: TEDU) and Aspen Group (NASDAQ:ASPU) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

  • [By Ethan Ryder]

    Tarena International (NASDAQ: TEDU) and TAL Education (NYSE:TAL) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

Top 10 Heal Care Stocks To Invest In Right Now: Leggett & Platt, Incorporated(LEG)

Advisors’ Opinion:

  • [By Logan Wallace]

    California Public Employees Retirement System boosted its stake in shares of Leggett & Platt, Inc. (NYSE:LEG) by 2.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 413,255 shares of the company’s stock after purchasing an additional 10,689 shares during the period. California Public Employees Retirement System owned about 0.31% of Leggett & Platt worth $18,332,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Leggett & Platt (NYSE: LEG) and Hooker Furniture (NASDAQ:HOFT) are both consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Leggett & Platt (LEG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Candriam Luxembourg S.C.A. decreased its position in shares of Leggett & Platt, Inc. (NYSE:LEG) by 7.6% in the 1st quarter, HoldingsChannel reports. The fund owned 39,994 shares of the company’s stock after selling 3,289 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Leggett & Platt were worth $1,774,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Shares of LEG Immobilien AG (FRA:LEG) have been assigned an average rating of “Buy” from the nineteen research firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is €101.62 ($118.16).

Top 10 Heal Care Stocks To Invest In Right Now: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Shane Hupp]

    Aimmune Therapeutics (NASDAQ:AIMT)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued to clients and investors on Wednesday. They currently have a $72.00 target price on the biotechnology company’s stock. Wedbush’s price objective points to a potential upside of 117.59% from the company’s previous close.

  • [By ]

    Aimmune Therapeutics (AIMT) : “I do like it. That’s an important niche business. “

    Ingersoll-Rand (IR) : “I like Ingersoll-Rand. They work well at this phase in the cycle.”

  • [By Chris Lange]

    Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed trading most recently at $37.13, with a consensus price target of $55.50 and a 52-week range of $15.97 to $40.65.

  • [By ]

    In the Lightning Round, Cramer was bullish on Ingersoll-Rand (IR) , The Blackstone Group (BX) , Thermo Fisher Scientific (TMO) , FMC Corp (FMC) , Nike (NKE) , Zebra Technologies (ZBRA) and Aimmune Therapeutics (AIMT) .

Top 10 Heal Care Stocks To Invest In Right Now: Bravo Brio Restaurant Group Inc.(BBRG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media coverage about Bravo Brio Restaurant Group (NASDAQ:BBRG) has trended positive on Saturday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bravo Brio Restaurant Group earned a daily sentiment score of 0.39 on Accern’s scale. Accern also assigned media coverage about the restaurant operator an impact score of 45.847415840944 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Heal Care Stocks To Invest In Right Now: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Max Byerly]

    Aclaris Therapeutics (NASDAQ:ACRS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania. “

  • [By Stephan Byrd]

    Headlines about Aclaris Therapeutics (NASDAQ:ACRS) have been trending somewhat positive on Thursday, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aclaris Therapeutics earned a news sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the biotechnology company an impact score of 46.9638334424702 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Aclaris Therapeutics (NASDAQ:ACRS) received a $50.00 price target from equities research analysts at Cantor Fitzgerald in a report issued on Tuesday. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 177.62% from the company’s current price.

Top 10 Heal Care Stocks To Invest In Right Now: Cherokee Inc.(CHKE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cherokee (NASDAQ:CHKE) released its quarterly earnings data on Thursday. The company reported ($0.20) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.09) by ($0.11), RTT News reports. Cherokee had a negative return on equity of 13.63% and a negative net margin of 130.24%. During the same quarter last year, the business posted ($0.07) earnings per share.

  • [By Garrett Baldwin]

    Following the June FOMC meeting, silver prices are hovering at very attractive price levels. With interest rates heading higher, it’s going to be a very good time for silver hounds to buy on the dip and deliver incredible profits in the months ahead.Learn more right here.

    The Top Stock Market Stories for Thursday
    On Thursday, the European Central Bank held its meeting in Latvia to discuss the future of its quantitative easing program. The central bank of the world’s largest economic bloc said that it will likely end its quantitative easing program in December. This represents an extension beyond the current plan to end the stimulus program in September. ECB President Mario Draghi said the program would be reduced to 15 billion euros each month during the final three months of the year. Yesterday, the U.S. Federal Reserve raised interest rates for the second time in 2018. The central bank said that economic growth has been rising at a solid rate and hinted that it could raise rates two more times this year. Fed Chair Jerome Powell did raise an alarm on Wednesday after stating that companies are holding back on investment due to ongoing concerns about U.S. President Donald Trump’s trade policies. Trump is expected to decide this week on whether to proceed with tariffs on about $50 billion in Chinese goods. Trade tensions are heating up again. This morning, China announced it would call off its deal to avoid a trade war if the Trump administration proceeds with tariffs on Friday morning. Tomorrow, the Trump team will decide if it will hit China with tariffs on roughly $50 billion in goods.
    Stocks to Watch Today: ADBE, CMCSA, TSLA, MSFT
    Adobe Systems Inc. (Nasdaq: ADBE) will report earnings after the bell Thursday. The software giant is expected to report earnings per share of $1.54 on top of $2.15 billion in revenue. Insider buying is alive and well at Tesla Inc. (Nasdaq: TSLA). Chair and CEO Elon Musk purchased $25 million in company stock, according to a

  • [By Max Byerly]

    Cherokee (NASDAQ: CHKE) and J.Jill (NYSE:JILL) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.